Fasting Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg
NCT00649077
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Meloxicam Tablets 15 mg
DRUG:
Mobic® Tablets 15 mg
Sponsor
Mylan Pharmaceuticals Inc